The "M" cell. a special effector cell system for rejection of hematopoietic grafts
South, M.A.
Cutis 22(1): 34; 39
1978
ISSN/ISBN: 0011-4162 PMID: 27336 Document Number: 126875
Document emailed within 1 workday
Related Documents
Jouet, J.P. 1997: Cell grafts: current and perspectives. I. Hematopoietic stem cell graft La Revue du Praticien 47(18 Spec No): S47-S49Finn, O.J.; Miceli, M.C. 1989: Effector T-cell repertoire selection in human allograft rejection Transplantation Proceedings 21(1 Pt 1): 346-348
Gilmer, P.J.; McDevitt, H.O.; McConnell, H.M. 1978: Inhibition of specific effector T cell-target cell conjugates by cell plasma membranes Journal of Immunology 120(3): 774-776
Chorváth, B.; Hunáková, L.; Turzová, M.; Sulíková, M.; Duraj, J.; Speiser, P.; Sedlák, J. 1992: Monoclonal antibodies to two adhesive cell surface antigens (CD43 and CD59) with different distribution on hematopoietic and non-hematopoietic tumor cell lines Neoplasma 39(6): 325-329
Fontan, J.; Mougin, C.; Cahn, J.Y. 1999: Human Herpesvirus 6: general information and infections in organ transplantations and hematopoietic stem cell grafts Presse Medicale 28(3): 149-156
Kondo, T.; Watarai, Y.; Novick, A.C.; Toma, H.; Fairchild, R.L. 1997: T cell-dependent acceleration of chemoattractant cytokine gene expression during secondary rejection of allogeneic skin grafts Transplantation 63(5): 732-742
Nozawa, S.; Tsukazaki, K.; Sakayori, M.; Jeng, C.H.; Iizuka, R. 1988: Establishment of a human ovarian clear cell carcinoma cell line (RMG-I) and its single cell cloning--with special reference to the stem cell of the tumor Human Cell 1(4): 426-435
Zarling, J.M.; Dierckins, M.S.; Sevenich, E.A.; Clouse, K.A. 1981: Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations Journal of Immunology 127(5): 2118-2123
Lim, S.M.; White, D.J.; Calne, R.Y. 1987: Minor and class i MHC incompatibilities do not cause rejection of heart grafts but influence the rejection of skin grafts Transplantation Proceedings 19(5): 4229-4230
Dennert, G. 1974: Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens Journal of Immunology 113(1): 201-208
Kurabe, N.; Arai, S.; Miyazaki, T. 2009: Cell cycle and cell sizing regulation via death effector domain Seikagaku. Journal of Japanese Biochemical Society 81(1): 24-27
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay Journal of Immunology 129(5): 2260-2265
Dupont, E.; Opelz, G.; Gustafsson, L.A.; Mikulski, S.M.; Terasaki, P.I. 1977: Depressed effector cell function in antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients Transplantation 23(2): 165-168
Ben-Nun, A.; Cohen, I.R. 1982: Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines Journal of Immunology 128(3): 1450-1457
Shalit, M.; Ayalon, M.; Weiss, L.; Leshem, B.; Kedar, E.; Slavin, S. 1986: Bone marrow transplantation with T-cell-depleted grafts. I. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted syngeneic bone marrow grafts Transplantation 42(2): 118-122
Sentman, C.L.; Olsson-Alheim, M.Y.; Lendahl, U.; Kärre, K. 1996: H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene Journal of Immunology 156(7): 2423-2429
Elknerová, K.; Lacinová, Z.; Soucek, J.; Marinov, I.; Stöckbauer, P. 2007: Growth inhibitory effect of the antibody to hematopoietic stem cell antigen CD34 in leukemic cell lines Neoplasma 54(4): 311-320
Redner, R.L.; Lee, A.W.; Osawa, G.A.; Nienhuis, A.W. 1992: Variable pattern of jun and fos gene expression in different hematopoietic cell lines during interleukin 3-induced entry into the cell cycle Oncogene 7(1): 43-50
Blazar, B.R.; Taylor, P.A.; Fitzsimmons, W.E.; Vallera, D.A. 1994: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation Journal of Immunology 153(4): 1836-1846
Jordan, C.T.; Yamasaki, G.; Minamoto, D. 1996: High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations Experimental Hematology 24(11): 1347-1355